Research & Development



  我倆沉默地對視。   逐條點開歷史記錄的網頁,與手機中的通訊記錄對照,大多數中介僅一兩次通話,其中只有一家,羅溫婉多次聯絡過。網頁上顯示的房子,地址是溫嶺路73號1號樓2單元302室。伊人在线大香蕉网4久草   因為這宅子里還有一個女人。大香蕉网伊人在线   她濃黑的長發里有一根紅線自腦中穿出,同閻先生手中的紅線交纏在一起,他將這兩根線一並繞在了“楊少卿”的脖子上。隨後湊到他耳邊,指著鏡子里他那張丑陋可怕的臉,淡淡一笑,道︰“楊典娘,被憤怒迷了心智殺了如此多無辜之人,時至今日,還沒能解脫出來麼?”   “這一世我中意的只有你。”窗內的楊少卿這樣道。色天使论坛最新地址   “他醫好了你的爹爹?”聞言清桐不由也愣了愣,有些費解,有些吃驚。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo